Avestar Capital’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.96M | Buy |
18,231
+1,332
| +8% | +$143K | 0.13% | 109 |
|
|
2025
Q1 | $1.7M | Sell |
16,899
-482
| -3% | -$48.6K | 0.15% | 104 |
|
|
2024
Q4 | $1.55M | Buy |
17,381
+4,984
| +40% | +$445K | 0.13% | 108 |
|
|
2024
Q3 | $1.04M | Buy |
12,397
+1,158
| +10% | +$97K | 0.11% | 138 |
|
|
2024
Q2 | $866K | Sell |
11,239
-1,122
| -9% | -$86.4K | 0.09% | 151 |
|
|
2024
Q1 | $847K | Buy |
12,361
+2,074
| +20% | +$142K | 0.09% | 151 |
|
|
2023
Q4 | $595K | Buy |
10,287
+892
| +9% | +$51.6K | 0.07% | 158 |
|
|
2023
Q3 | $496K | Buy |
9,395
+20
| +0.2% | +$1.06K | 0.07% | 154 |
|
|
2023
Q2 | $507K | Buy |
9,375
+1,033
| +12% | +$55.9K | 0.08% | 132 |
|
|
2023
Q1 | $417K | Buy |
8,342
+560
| +7% | +$28K | 0.07% | 152 |
|
|
2022
Q4 | $360K | Sell |
7,782
-225
| -3% | -$10.4K | 0.07% | 164 |
|
|
2022
Q3 | $310K | Sell |
8,007
-680
| -8% | -$26.3K | 0.08% | 161 |
|
|
2022
Q2 | $324K | Buy |
8,687
+1,936
| +29% | +$72.2K | 0.08% | 173 |
|
|
2022
Q1 | $299K | Buy |
6,751
+408
| +6% | +$18.1K | 0.05% | 277 |
|
|
2021
Q4 | $269K | Buy |
6,343
+1,026
| +19% | +$43.5K | 0.03% | 293 |
|
|
2021
Q3 | $231K | Buy |
5,317
+148
| +3% | +$6.43K | 0.03% | 312 |
|
|
2021
Q2 | $221K | Buy |
+5,169
| New | +$221K | 0.03% | 323 |
|
|
2019
Q3 | – | Sell |
-159
| Closed | -$5K | – | 262 |
|
|
2019
Q2 | $5K | Hold |
159
| – | – | ﹤0.01% | 576 |
|
|
2019
Q1 | $4K | Hold |
159
| – | – | ﹤0.01% | 587 |
|
|
2018
Q4 | $4K | Hold |
159
| – | – | ﹤0.01% | 551 |
|
|
2018
Q3 | $4K | Sell |
159
-4
| -2% | -$101 | ﹤0.01% | 564 |
|
|
2018
Q2 | $2K | Sell |
163
-22
| -12% | -$270 | ﹤0.01% | 666 |
|
|
2018
Q1 | $3K | Buy |
185
+29
| +19% | +$470 | ﹤0.01% | 590 |
|
|
2017
Q4 | $2K | Buy |
+156
| New | +$2K | ﹤0.01% | 617 |
|